434 related articles for article (PubMed ID: 35729567)
41. Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration.
Zhang D; Lu W; Zhuo Z; Mei H; Wu X; Cui Y
Discov Oncol; 2022 Aug; 13(1):78. PubMed ID: 35988113
[TBL] [Abstract][Full Text] [Related]
42. miRNA-874-3p inhibits the migration, invasion and proliferation of breast cancer cells by targeting VDAC1.
Yang H; Wang Z; Hu S; Chen L; Li W; Yang Z
Aging (Albany NY); 2023 Jan; 15(3):705-717. PubMed ID: 36750173
[TBL] [Abstract][Full Text] [Related]
43. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
44. Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer.
Yao Y; Kong X; Liu R; Xu F; Liu G; Sun C
Front Immunol; 2022; 13():845093. PubMed ID: 35558081
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
46. Bioinformatics analysis of prognosis and immune microenvironment of immunological cell death-related gemcitabine-resistance genes in bladder cancer.
Liu C; Wang XL; Shen EC; Wang BZ; Meng R; Cui Y; Wang WJ; Shao Q
Transl Androl Urol; 2022 Dec; 11(12):1715-1728. PubMed ID: 36632166
[TBL] [Abstract][Full Text] [Related]
47. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
Zhang B; Wang Q; Fu C; Jiang C; Ma S
Ann Transl Med; 2019 Dec; 7(23):730. PubMed ID: 32042746
[TBL] [Abstract][Full Text] [Related]
48. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
[TBL] [Abstract][Full Text] [Related]
49. Identification and development of an independent immune-related genes prognostic model for breast cancer.
Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R
BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008
[TBL] [Abstract][Full Text] [Related]
50. Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
Liu Z; Liu J; Liu R; Xue M; Zhang W; Zhao X; Zhu J; Xia P
BMC Cancer; 2021 Apr; 21(1):367. PubMed ID: 33827486
[TBL] [Abstract][Full Text] [Related]
51. Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer.
Yan LR; Wang A; Lv Z; Yuan Y; Xu Q
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439992
[TBL] [Abstract][Full Text] [Related]
52. Identification of
Zou J; Chen Y; Ji Z; Liu D; Chen X; Chen M; Chen K; Lin H; Chen Y; Li Z
Transl Cancer Res; 2024 Jan; 13(1):25-45. PubMed ID: 38410217
[TBL] [Abstract][Full Text] [Related]
53. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
54. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
[No Abstract] [Full Text] [Related]
55. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
[TBL] [Abstract][Full Text] [Related]
56. High Expression of TIMM17B Is a Potential Diagnostic and Prognostic Marker of Breast Cancer.
Mingting Duan ; Yun Ren ; Jiwen Zhang ; Tingting Zhang ; Yanhong Wang ; Hongyan Jia
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):169-176. PubMed ID: 37300670
[TBL] [Abstract][Full Text] [Related]
57. A Novel Prognostic Biomarker of Luminal Breast Cancer: High CD39 Expression Is Related to Poor Survival.
Ni X; Wan W; Ma J; Liu X; Zheng B; He Z; Yang W; Huang L
Front Genet; 2021; 12():682503. PubMed ID: 34220957
[TBL] [Abstract][Full Text] [Related]
58. Immune-related gene data-based molecular subtyping related to the prognosis of breast cancer patients.
Mu G; Ji H; He H; Wang H
Breast Cancer; 2021 Mar; 28(2):513-526. PubMed ID: 33245478
[TBL] [Abstract][Full Text] [Related]
59. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
[TBL] [Abstract][Full Text] [Related]
60. Expression and clinical prognostic value of CYB561 in breast cancer.
Zhou X; Shen G; Ren D; Guo X; Han J; Guo Q; Zhao F; Wang M; Dong Q; Li Z; Zhao J
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1879-1892. PubMed ID: 35486183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
